CMS waives Part D late enrollment fee for some

22 January 2007

The US Centers for Medicare and Medicaid Services (CMS) has announced that the late enrollment penalty for the Medicare Part D prescription drug benefit will once again be waived for low-income beneficiaires (Marketletters passim). The decision was welcomed as "a good move" by Senator Charles Grassley (Republican, Iowa), who previously sponsored legislation to abolish the penalty for all applicants.

Acting CMS Administrator, Leslie Norwalk, explained the decision: "this is our most difficult population to reach and the one for which we continue to focus our efforts." Last year, the first for which the prescription drug benefit was implemented, enrollment rates for low-income patients were lower than for the higher-income population.

30 million hits on drug benefit web site

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight